A COMPREHENSIVE META-ANALYSIS AND REVIEW ON THE ANTIARTHRITIC EFFECTS OF CAMPESTEROL: INSIGHTS INTO MECHANISTIC ACTION

S NAZIR; A MOBASHAR; WA CHAUDHARY; S JAVAID; K ASIF; M SIDDIQUE

doi:10.54112/bcsrj.v2023i1.371

Authors

S NAZIR Faculty of Pharmacy, University of Lahore, Lahore Pakistan
A MOBASHAR Faculty of Pharmacy, University of Lahore, Lahore Pakistan
WA CHAUDHARY Department of Pain Management. University of Leicester, England
S JAVAID Department of Pharmaceutical Chemistry, Rashid Latif College of Pharmacy Lahore, Pakistan
K ASIF Department of Pharmacology & Therapeutics, Rashid Latif College of Pharmacy, Rashid Latif Khan, University, Lahore Pakistan/ University of Sargodha, Lahore Pakistan.
M SIDDIQUE Department of Pharmacology & Therapeutics, Yashfeen College of Pharmacy, Yashfeen Education System, (Pharmacology), Institute of Pharmacy, Lahore College for Women University, Lahore, Pakistan.

DOI:

https://doi.org/10.54112/bcsrj.v2023i1.371

Keywords:

Campesterol, Rheumatoid Arthritis, AntiInflammatory, ProInflammatory Cytokines, MetaAnalysis.

Abstract

Delving into the potential therapeutic benefits of Campesterol, a plant-derived sterol, this comprehensive metaanalysis and review systematically dissect its role in combating arthritis. The focus is primarily on the reported ability of Campesterol to suppress vital proinflammatory markers such as TNF-α, IL1β, IL-6, NFκ-B, MMP-3, COX-I, and COX-II, and its potential to stimulate the anti-inflammatory cytokine IL-4. Rheumatoid arthritis (RA) is a chronic inflammatory condition recognized for deleterious impact on joint structures. This meta-analysis and review aim to elucidate the potential therapeutic advantages of Campesterol, a phytosterol renowned for its anti-inflammatory properties, in managing rheumatoid arthritis (RA). Through the systematic compilation of evidence from various studies, our objective is to elucidate the precise mechanism of action by which Campesterol exerts its antiarthritic effects. This meta-analysis, conducted in adherence to the PRISMA guidelines, encompasses studies until July 2023. The primary objective is to comprehend the function of Campesterol in regulating both pro and anti-inflammatory indicators in rheumatoid arthritis (RA). The reliability of the studies included in the analysis was assessed using standardized evaluation instruments. A noteworthy study conducted on a rat model with arthritis induced by CFA (Complete Freund's Adjuvant) presents compelling evidence supporting the antiarthritic properties of Campesterol. Administration of Campesterol resulted in a notable decrease in arthritic scores, paw edema, and levels of proinflammatory cytokines, including TNF-α, NFκ-B, IL-6, COX-II, and IL-1. Additionally, the levels of PGE-2 were also reduced. Moreover, it elicited an increase in anti-inflammatory interleukin4 (IL-4) levels and restored homeostasis in blood and biochemical parameters, indicating a comprehensive amelioration in the pathology of arthritis. These findings were further supported by additional studies, highlighting the potential of Campesterol as a potent therapeutic agent in managing rheumatoid arthritis (RA). This meta-analysis strongly supports the therapeutic potential of Campesterol in treating arthritis. However, additional research, particularly involving human trials, is required to substantiate these findings and gain a comprehensive understanding of the therapeutic potential of Campesterol in the management of arthritis. Further investigations are warranted to explore the intricate aspects of Campesterol's pharmacokinetics and pharmacodynamics and its enduring safety profile. Additionally, it is imperative to examine the potential synergistic interactions that may arise when Campesterol is combined with established treatments for rheumatoid arthritis (RA). It is imperative to investigate Campesterol's precise molecular targets further.

Downloads

Download data is not yet available.

References

Abellan van Kan, G., Rolland, Y., and Andrieu, S. (2009). Nutrition and physiologic function. J Nutr Health Aging 13, 881-889.

Baek, G., Lee, H., Ko, J., and Choi, H.-K. (2022). Exogenous melatonin enhances the growth and production of bioactive metabolites in Lemna aequinoctialis culture by modulating metabolic and lipidomic profiles. BMC Plant Biology 22, 545.

Basta, F., Fasola, F., Triantafyllias, K., and Schwarting, A. (2020). Systemic lupus erythematosus (SLE) therapy: the old and the new. Rheumatology and Therapy 7, 433-446.

Bootsma, H., Spronk, P., de Boer, G., Limburg, P., Kallenberg, C., Derksen, R., Wolters-Dicke, J., Gmelig-Meyling, F., Kater, L., and Hermans, J. (1995). Prevention of relapses in systemic lupus erythematosus. The Lancet 345, 1595-1599.

Cardoso, B. R., Duarte, G. B. S., Reis, B. Z., and Cozzolino, S. M. (2017). Brazil nuts: Nutritional composition, health benefits and safety aspects. Food Research International 100, 9-18.

Ghasemian, M., Owlia, S., and Owlia, M. B. (2016). Review of anti-inflammatory herbal medicines. Advances in Pharmacological and Pharmaceutical Sciences 2016.

Grattan Jr, B. J. (2013). Plant sterols as anticancer nutrients: evidence for their role in breast cancer. Nutrients 5, 359-387.

Gurevitz, S., Snyder, J., Wessel, E., Frey, J., and Williamson, B. (2013). Systemic lupus erythematosus: a review of the disease and treatment options. The Consultant Pharmacist® 28, 110-121.

Kuhn, A., Bonsmann, G., Anders, H.-J., Herzer, P., Tenbrock, K., and Schneider, M. (2015). The diagnosis and treatment of systemic lupus erythematosus. Deutsches Ärzteblatt International 112, 423.

Mikołajczak, N., Sobiechowska, D. A., and Tańska, M. (2020). Edible flowers as a new source of natural antioxidants for oxidative protection of cold-pressed oils rich in omega-3 fatty acids. Food Research International 134, 109216.

Misra, K., Sharma, P., and Bhardwaj, A. (2018). "Management of high altitude pathophysiology," Academic Press.

Schwartz, N., Stock, A. D., and Putterman, C. (2019). Neuropsychiatric lupus: new mechanistic insights and future treatment directions. Nature Reviews Rheumatology 15, 137-152.

Wallace, D. J. (2015). The evolution of drug discovery in systemic lupus erythematosus. Nature Reviews Rheumatology 11, 616-620.

Wang, X., Wang, Y., Zhou, Y., Li, J., Yin, W., Wang, S., Zhang, S., Shen, J., Shen, Z., and Wang, Y. (2018). Emergence of a novel mobile colistin resistance gene, mcr-8, in NDM-producing Klebsiella pneumoniae. Emerging microbes & infections 7, 1-9.

Yuan, L., Zhang, F., Shen, M., Jia, S., and Xie, J. (2019). Phytosterols suppress phagocytosis and inhibit inflammatory mediators via ERK pathway on LPS-triggered inflammatory responses in RAW264. 7 macrophages and the correlation with their structure. Foods 8, 582.